CN Patent

CN103748095B — 二环杂芳族化合物

Assigned to Merck Patent GmbH · Expires 2016-11-30 · 9y expired

What this patent protects

式I化合物（其中X 1 、X 2 、X 3 、X 4 、X 5 、R 1 、R 2 、R 3 、R 4 、R 5 和R 6 具有在权利要求1中指出的含义）是激酶抑制剂，且除了别的用途以外，可以用于治疗肿瘤。

USPTO Abstract

式I化合物（其中X 1 、X 2 、X 3 、X 4 、X 5 、R 1 、R 2 、R 3 、R 4 、R 5 和R 6 具有在权利要求1中指出的含义）是激酶抑制剂，且除了别的用途以外，可以用于治疗肿瘤。

Drugs covered by this patent

Patent Metadata

Patent number
CN103748095B
Jurisdiction
CN
Classification
—
Expires
2016-11-30
Drug substance claim
No
Drug product claim
No
Assignee
Merck Patent GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.